IV selexipag can be used as a bridging therapy

PHA Canada
Jun 9, 2025
1 min read

Pulmonary arterial hypertension patients who take selexipag normally take it orally (as a pill). Sometimes, though, this is temporarily impossible. People might be unable to swallow or have other medical conditions that interfere with their ability to take pills. A small study looked at whether temporarily giving selexipag as an intravenous infusion was safe and effective. They found that it was.

Read the Therapeutics and Clinical Risk Management paper

Recent Posts

Review finds selexipag is well tolerated in children

A review of 12 studies evaluating selexipag in pediatric patients with pulmonary arterial hypertension found that it improved functional capacity and mPAP, especially when added to existing therapies.

Sotatercept might help treat portopulmonary hypertension

Patients with portopulmonary hypertension were not included in clinical trials for sotatercept. This case report found that sotatercept helped one patient with portopulmonary hypertension, who was the

Exercise is safe and effective for PH patients

Researchers conducted a meta-analysis, looking at 13 studies with about 700 participants in total with pulmonary hypertension (PH). They found that exercise improved 6-minute walk distance and was con

Comments